
Shandong Lukang Pharmaceutical Co.,Ltd.
SSE:600789.SS
10.9 (CNY) • At close June 6, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 6,233.09 | 6,092.961 | 5,621.442 | 4,890.673 | 4,205.109 | 3,732.719 | 3,329.605 | 2,599.289 | 2,505.592 | 2,410.288 | 2,312.103 | 2,210.685 | 2,339.454 | 2,332.873 | 2,196.145 | 1,985.117 | 1,789.442 | 1,462.411 | 1,113.64 | 1,155.936 | 1,027.522 | 974.193 | 1,039.48 | 771.137 | 701.322 | 592.742 | 563.448 | 690.619 | 597.519 | 487.369 | 434.544 | 396.541 |
Cost of Revenue
| 4,739.469 | 4,685.951 | 4,373.962 | 3,744.179 | 3,224.977 | 2,677.036 | 2,292.497 | 1,889.917 | 1,917.04 | 1,935.614 | 1,898.961 | 1,840.963 | 2,014.33 | 1,966.57 | 1,722.725 | 1,660.527 | 1,483.818 | 1,188.153 | 973.682 | 1,013.403 | 900.05 | 719.192 | 761.085 | 583.843 | 512.068 | 465.659 | 426.349 | 520.085 | 440.401 | 344.758 | 318.466 | 275.957 |
Gross Profit
| 1,493.621 | 1,407.01 | 1,247.48 | 1,146.493 | 980.132 | 1,055.683 | 1,037.108 | 709.372 | 588.552 | 474.674 | 413.142 | 369.723 | 325.125 | 366.303 | 473.42 | 324.59 | 305.624 | 274.257 | 139.958 | 142.533 | 127.471 | 255.001 | 278.395 | 187.295 | 189.254 | 127.083 | 137.099 | 170.534 | 157.118 | 142.611 | 116.078 | 120.584 |
Gross Profit Ratio
| 0.24 | 0.231 | 0.222 | 0.234 | 0.233 | 0.283 | 0.311 | 0.273 | 0.235 | 0.197 | 0.179 | 0.167 | 0.139 | 0.157 | 0.216 | 0.164 | 0.171 | 0.188 | 0.126 | 0.123 | 0.124 | 0.262 | 0.268 | 0.243 | 0.27 | 0.214 | 0.243 | 0.247 | 0.263 | 0.293 | 0.267 | 0.304 |
Reseach & Development Expenses
| 317.147 | 345.785 | 275.835 | 254.302 | 192.635 | 140.849 | 125.615 | 96.988 | 109.064 | 45.41 | 37.158 | 28.074 | 25.376 | 24.982 | 20.175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 48.839 | 56.38 | 44.126 | 54.127 | 46.663 | 41.638 | 35.658 | 33.676 | 38.447 | 40.212 | 52.445 | 67.07 | 25.484 | 21.514 | 23.929 | 89.406 | 81.392 | 80.862 | 113.96 | 81.526 | 122.642 | 85.746 | 73.255 | 45.513 | 38.973 | 26.277 | 38.19 | 39.558 | 33.323 | 36.878 | 25.105 | 28.821 |
Selling & Marketing Expenses
| 410.41 | 419.634 | 475.088 | 479.618 | 460.207 | 543.975 | 486.882 | 297.165 | 234.817 | 203.019 | 221.414 | 202.689 | 215.465 | 183.606 | 171.678 | 135.76 | 117.531 | 110.376 | 65.433 | 37.526 | 59.262 | 39.035 | 41.482 | 35.22 | 67.399 | 57.248 | 24.386 | 28.012 | 15.978 | 8.85 | 8.756 | 7.697 |
SG&A
| 459.249 | 811.191 | 519.214 | 533.745 | 506.871 | 585.613 | 522.539 | 330.841 | 273.264 | 243.231 | 273.858 | 269.758 | 240.948 | 205.12 | 195.607 | 225.166 | 198.924 | 191.238 | 179.393 | 119.051 | 181.904 | 124.781 | 114.736 | 80.732 | 106.372 | 83.525 | 62.577 | 67.57 | 49.301 | 45.728 | 33.861 | 36.519 |
Other Expenses
| 281.036 | 31.661 | 159.346 | 124.398 | 121.334 | 107.562 | 5.238 | 10.831 | 9.81 | 9.673 | 2.338 | 124.418 | 11.941 | 41.927 | 15.644 | 12.818 | 9.774 | -1.556 | -1.798 | 5.278 | 1.285 | 4.658 | 1.727 | 2.55 | 6.571 | 3.596 | 2.879 | 13.286 | 13.113 | 1.87 | 1.725 | 0.981 |
Operating Expenses
| 1,057.432 | 1,188.637 | 954.395 | 912.445 | 820.84 | 834.024 | 747.844 | 503.162 | 505.823 | 413.385 | 434.541 | 417.123 | 364.318 | 318.1 | 292.909 | 237.943 | 209.763 | 199.419 | 187.721 | 126.144 | 186.628 | 131.164 | 123.505 | 86.764 | 112.687 | 86.496 | 65.718 | 73.28 | 51.046 | 46.106 | 36.355 | 72.375 |
Operating Income
| 436.19 | 272.133 | 307.668 | 226.901 | 154.775 | 257.502 | 187.076 | 129.128 | 26.474 | 7.46 | -134.045 | -114.914 | -137.837 | -14.233 | 135.157 | 35.267 | 33.754 | 28.052 | -95.429 | 2.241 | -94.779 | 75.406 | 123.935 | 82.513 | 70.36 | 54.633 | 70.081 | 103.719 | 91.931 | 83.923 | 72.432 | 40.385 |
Operating Income Ratio
| 0.07 | 0.045 | 0.055 | 0.046 | 0.037 | 0.069 | 0.056 | 0.05 | 0.011 | 0.003 | -0.058 | -0.052 | -0.059 | -0.006 | 0.062 | 0.018 | 0.019 | 0.019 | -0.086 | 0.002 | -0.092 | 0.077 | 0.119 | 0.107 | 0.1 | 0.092 | 0.124 | 0.15 | 0.154 | 0.172 | 0.167 | 0.102 |
Total Other Income Expenses Net
| -2.288 | 0.842 | -157.572 | -113.323 | -5.205 | -108.683 | 5.238 | 10.831 | 9.467 | 9.562 | 1.951 | 123.041 | -43.204 | 41.285 | 5.158 | -40.785 | -54.647 | -5.218 | -0.782 | -17.656 | -38.69 | 3.005 | -2.684 | -0.519 | -2.884 | -0.114 | 0.771 | 7.686 | 8.913 | -0.309 | -0.415 | -0.242 |
Income Before Tax
| 433.901 | 272.975 | 150.095 | 106.257 | 262.161 | 148.819 | 192.314 | 139.96 | 36.137 | 17.022 | -132.093 | 8.127 | -126.859 | 27.052 | 150.599 | 45.862 | 41.214 | 26.497 | -96.211 | 3.126 | -95.67 | 78.41 | 122.997 | 81.994 | 70.422 | 54.519 | 70.851 | 111.405 | 100.844 | 83.614 | 72.017 | 40.143 |
Income Before Tax Ratio
| 0.07 | 0.045 | 0.027 | 0.022 | 0.062 | 0.04 | 0.058 | 0.054 | 0.014 | 0.007 | -0.057 | 0.004 | -0.054 | 0.012 | 0.069 | 0.023 | 0.023 | 0.018 | -0.086 | 0.003 | -0.093 | 0.08 | 0.118 | 0.106 | 0.1 | 0.092 | 0.126 | 0.161 | 0.169 | 0.172 | 0.166 | 0.101 |
Income Tax Expense
| 25.554 | 16.188 | 6.98 | 22.779 | 28.676 | 20.032 | 18.882 | 11.032 | 6.63 | 9.452 | 4.597 | 4.019 | 4.566 | 8.229 | 16.767 | 5.183 | 2.41 | 0.395 | 0.308 | 0.051 | 0.058 | 24.29 | 25.375 | 11.534 | 10.667 | 8.25 | 23.381 | 16.839 | 15.127 | 8.036 | 10.803 | 7.851 |
Net Income
| 394.616 | 246.172 | 138.013 | 89.099 | 227.877 | 121.251 | 161.387 | 114.237 | 29.102 | 7.897 | -125.215 | 10.858 | -133.834 | 15.013 | 129.611 | 37.58 | 35.205 | 25.974 | -96.538 | 4.977 | -92.348 | 54.12 | 97.622 | 70.46 | 59.755 | 46.269 | 60.224 | 94.566 | 85.717 | 65.964 | 61.214 | 32.291 |
Net Income Ratio
| 0.063 | 0.04 | 0.025 | 0.018 | 0.054 | 0.032 | 0.048 | 0.044 | 0.012 | 0.003 | -0.054 | 0.005 | -0.057 | 0.006 | 0.059 | 0.019 | 0.02 | 0.018 | -0.087 | 0.004 | -0.09 | 0.056 | 0.094 | 0.091 | 0.085 | 0.078 | 0.107 | 0.137 | 0.143 | 0.135 | 0.141 | 0.081 |
EPS
| 0.44 | 0.27 | 0.16 | 0.1 | 0.26 | 0.14 | 0.19 | 0.15 | 0.039 | 0.008 | -0.17 | 0.015 | -0.18 | 0.023 | 0.17 | 0.046 | 0.046 | 0.031 | -0.17 | 0.006 | -0.11 | 0.06 | 0.12 | 0.087 | 0.071 | 0.057 | 0.073 | 0.13 | 0.1 | 0.078 | 0.073 | 0.038 |
EPS Diluted
| 0.44 | 0.27 | 0.15 | 0.1 | 0.25 | 0.14 | 0.19 | 0.15 | 0.039 | 0.008 | -0.17 | 0.015 | -0.18 | 0.023 | 0.17 | 0.046 | 0.046 | 0.031 | -0.17 | 0.006 | -0.11 | 0.06 | 0.12 | 0.087 | 0.071 | 0.057 | 0.073 | 0.13 | 0.1 | 0.078 | 0.073 | 0.038 |
EBITDA
| 910.886 | 741.886 | 611.593 | 486.169 | 570.679 | 392.54 | 393.691 | 315.971 | 233.512 | 252.534 | 133.748 | 277.862 | 103.908 | 236.319 | 336.007 | 244.543 | 248.774 | 210.079 | 79.895 | 176.808 | 67.972 | 216.378 | 257.55 | 177.892 | 165.602 | 71.614 | 99.982 | 97.254 | 106.072 | 96.505 | 79.723 | 48.209 |
EBITDA Ratio
| 0.146 | 0.122 | 0.109 | 0.099 | 0.136 | 0.105 | 0.118 | 0.122 | 0.093 | 0.105 | 0.058 | 0.126 | 0.044 | 0.101 | 0.153 | 0.123 | 0.139 | 0.144 | 0.072 | 0.153 | 0.066 | 0.222 | 0.248 | 0.231 | 0.236 | 0.121 | 0.177 | 0.141 | 0.178 | 0.198 | 0.183 | 0.122 |